Cargando…
The prognostic value of measurement of high-sensitive cardiac troponin T for mortality in a cohort of stable chronic obstructive pulmonary disease patients
BACKGROUND: Cardiovascular disease (CVD) is a common comorbidity in chronic obstructive pulmonary disease (COPD). Cardiac troponin (cTn) elevation, indicating myocardial injury, is frequent during acute COPD exacerbations and associated with increased mortality. The prognostic value of circulating c...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5124304/ https://www.ncbi.nlm.nih.gov/pubmed/27887619 http://dx.doi.org/10.1186/s12890-016-0319-9 |
_version_ | 1782469840895737856 |
---|---|
author | Neukamm, Anke Einvik, Gunnar Didrik Høiseth, Arne Søyseth, Vidar Henrik Holmedahl, Nils Kononova, Natalia Omland, Torbjørn |
author_facet | Neukamm, Anke Einvik, Gunnar Didrik Høiseth, Arne Søyseth, Vidar Henrik Holmedahl, Nils Kononova, Natalia Omland, Torbjørn |
author_sort | Neukamm, Anke |
collection | PubMed |
description | BACKGROUND: Cardiovascular disease (CVD) is a common comorbidity in chronic obstructive pulmonary disease (COPD). Cardiac troponin (cTn) elevation, indicating myocardial injury, is frequent during acute COPD exacerbations and associated with increased mortality. The prognostic value of circulating cTnT among COPD patients in the stable state of the disease is still unknown. The purpose of the present study was to assess the association between circulating cTnT measured by a high sensitive assay (hs-cTnT) and all-cause mortality among patients with stable COPD without overt CVD. METHODS: In a prospective cohort study we included 275 patients from the Akershus University Hospital’s outpatient clinic and from Glittre, a pulmonary rehabilitation clinic. COPD-severity and cardiovascular risk factors were assessed, and time to all-cause death was recorded during a mean follow-up time of 2.8 years. RESULTS: One hundred-eighty patients (65%) had hs-cTnT concentrations ≥ the level of detection (5.0 ng/L) and 66 patients (24%) had hs-cTnT above the normal range (≥14.0 ng/L). In total, 47 patients (17%) died. hs-cTnT concentrations in the ranges <5.0, 5.0–13.9 and ≥14 ng/L were associated with crude mortality rates of 2.8, 4.4 and 11.0 per 100 patient-years, respectively. In adjusted analyses the hazard ratios (95% confidence intervals) for death were 1.7 (0.8–3.9) and 2.9 (1.2–7.2) among patients with hs-cTnT concentrations 5.0–13.9 and ≥14 ng/L, respectively, compared to patients with hs-cTnT <5.0 ng/L. CONCLUSIONS: hs-cTnT elevation is frequently present in patients with stable COPD without overt CVD, and associated with increased mortality, independently of COPD-severity and other cardiovascular risk factors. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12890-016-0319-9) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5124304 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-51243042016-12-08 The prognostic value of measurement of high-sensitive cardiac troponin T for mortality in a cohort of stable chronic obstructive pulmonary disease patients Neukamm, Anke Einvik, Gunnar Didrik Høiseth, Arne Søyseth, Vidar Henrik Holmedahl, Nils Kononova, Natalia Omland, Torbjørn BMC Pulm Med Research Article BACKGROUND: Cardiovascular disease (CVD) is a common comorbidity in chronic obstructive pulmonary disease (COPD). Cardiac troponin (cTn) elevation, indicating myocardial injury, is frequent during acute COPD exacerbations and associated with increased mortality. The prognostic value of circulating cTnT among COPD patients in the stable state of the disease is still unknown. The purpose of the present study was to assess the association between circulating cTnT measured by a high sensitive assay (hs-cTnT) and all-cause mortality among patients with stable COPD without overt CVD. METHODS: In a prospective cohort study we included 275 patients from the Akershus University Hospital’s outpatient clinic and from Glittre, a pulmonary rehabilitation clinic. COPD-severity and cardiovascular risk factors were assessed, and time to all-cause death was recorded during a mean follow-up time of 2.8 years. RESULTS: One hundred-eighty patients (65%) had hs-cTnT concentrations ≥ the level of detection (5.0 ng/L) and 66 patients (24%) had hs-cTnT above the normal range (≥14.0 ng/L). In total, 47 patients (17%) died. hs-cTnT concentrations in the ranges <5.0, 5.0–13.9 and ≥14 ng/L were associated with crude mortality rates of 2.8, 4.4 and 11.0 per 100 patient-years, respectively. In adjusted analyses the hazard ratios (95% confidence intervals) for death were 1.7 (0.8–3.9) and 2.9 (1.2–7.2) among patients with hs-cTnT concentrations 5.0–13.9 and ≥14 ng/L, respectively, compared to patients with hs-cTnT <5.0 ng/L. CONCLUSIONS: hs-cTnT elevation is frequently present in patients with stable COPD without overt CVD, and associated with increased mortality, independently of COPD-severity and other cardiovascular risk factors. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12890-016-0319-9) contains supplementary material, which is available to authorized users. BioMed Central 2016-11-25 /pmc/articles/PMC5124304/ /pubmed/27887619 http://dx.doi.org/10.1186/s12890-016-0319-9 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Neukamm, Anke Einvik, Gunnar Didrik Høiseth, Arne Søyseth, Vidar Henrik Holmedahl, Nils Kononova, Natalia Omland, Torbjørn The prognostic value of measurement of high-sensitive cardiac troponin T for mortality in a cohort of stable chronic obstructive pulmonary disease patients |
title | The prognostic value of measurement of high-sensitive cardiac troponin T for mortality in a cohort of stable chronic obstructive pulmonary disease patients |
title_full | The prognostic value of measurement of high-sensitive cardiac troponin T for mortality in a cohort of stable chronic obstructive pulmonary disease patients |
title_fullStr | The prognostic value of measurement of high-sensitive cardiac troponin T for mortality in a cohort of stable chronic obstructive pulmonary disease patients |
title_full_unstemmed | The prognostic value of measurement of high-sensitive cardiac troponin T for mortality in a cohort of stable chronic obstructive pulmonary disease patients |
title_short | The prognostic value of measurement of high-sensitive cardiac troponin T for mortality in a cohort of stable chronic obstructive pulmonary disease patients |
title_sort | prognostic value of measurement of high-sensitive cardiac troponin t for mortality in a cohort of stable chronic obstructive pulmonary disease patients |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5124304/ https://www.ncbi.nlm.nih.gov/pubmed/27887619 http://dx.doi.org/10.1186/s12890-016-0319-9 |
work_keys_str_mv | AT neukammanke theprognosticvalueofmeasurementofhighsensitivecardiactroponintformortalityinacohortofstablechronicobstructivepulmonarydiseasepatients AT einvikgunnar theprognosticvalueofmeasurementofhighsensitivecardiactroponintformortalityinacohortofstablechronicobstructivepulmonarydiseasepatients AT didrikhøisetharne theprognosticvalueofmeasurementofhighsensitivecardiactroponintformortalityinacohortofstablechronicobstructivepulmonarydiseasepatients AT søysethvidar theprognosticvalueofmeasurementofhighsensitivecardiactroponintformortalityinacohortofstablechronicobstructivepulmonarydiseasepatients AT henrikholmedahlnils theprognosticvalueofmeasurementofhighsensitivecardiactroponintformortalityinacohortofstablechronicobstructivepulmonarydiseasepatients AT kononovanatalia theprognosticvalueofmeasurementofhighsensitivecardiactroponintformortalityinacohortofstablechronicobstructivepulmonarydiseasepatients AT omlandtorbjørn theprognosticvalueofmeasurementofhighsensitivecardiactroponintformortalityinacohortofstablechronicobstructivepulmonarydiseasepatients AT neukammanke prognosticvalueofmeasurementofhighsensitivecardiactroponintformortalityinacohortofstablechronicobstructivepulmonarydiseasepatients AT einvikgunnar prognosticvalueofmeasurementofhighsensitivecardiactroponintformortalityinacohortofstablechronicobstructivepulmonarydiseasepatients AT didrikhøisetharne prognosticvalueofmeasurementofhighsensitivecardiactroponintformortalityinacohortofstablechronicobstructivepulmonarydiseasepatients AT søysethvidar prognosticvalueofmeasurementofhighsensitivecardiactroponintformortalityinacohortofstablechronicobstructivepulmonarydiseasepatients AT henrikholmedahlnils prognosticvalueofmeasurementofhighsensitivecardiactroponintformortalityinacohortofstablechronicobstructivepulmonarydiseasepatients AT kononovanatalia prognosticvalueofmeasurementofhighsensitivecardiactroponintformortalityinacohortofstablechronicobstructivepulmonarydiseasepatients AT omlandtorbjørn prognosticvalueofmeasurementofhighsensitivecardiactroponintformortalityinacohortofstablechronicobstructivepulmonarydiseasepatients |